How best to serve patients' interests in large clinical trials? Martine Piccart, Aron Goldhirsch and their colleagues argue that maintaining academic independence is essential to early breast cancer trials.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Concordance as evidence in the Watson for Oncology decision-support system
AI & SOCIETY Open Access 01 February 2020
-
Conflict of interest in academic oncology: moving beyond the blame game and forging a path forward
Blood Cancer Journal Open Access 04 November 2016
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Early Breast Cancer Trialists' Collaborative Group Lancet 365, 1687–717 (2005).
Giordano, S. H., Duan, Z., Kuo, Y. F., Hortobagyi, G. N. & Goodwin, J. S. J. Clin. Oncol. 18, 2750–2756 (2006).
Regan, M. M. & Gelber, R. D. Breast 14, 582–593 (2005).
NIH Adjuvant Therapy for Breast Cancer available at http://consensus.nih.gov/2000/2000AdjuvantTherapyBreastCancer114html.htm (2000).
Mello, M. M., Clarridge, B. R. & Studdert, D. M. N. Engl. J. Med. 352, 2202–2210 (2005).
Gilpin, K. N. New York Times (2 June 2004).
Angell, M. The New York Review of Books 53(10), (2006).
Drazen, J. M. N. Engl. J. Med. 347, 1362–1363 (2002).
World Medical Association Declaration of Helsinki (http://www.wma.net/e/policy/b3.htm).
Goss, P. E. et al. N. Engl. J. Med. 349, 1793–1802 (2003).
Piccart-Gebhart, M. J. et al. N. Engl. J. Med. 353, 1659–1672 (2005).
Thürlimann, B. et al. N. Engl. J. Med. 353, 2747–2757 (2005).
Coombes, R. C. et al. N. Engl. J. Med. 350, 1081–1092 (2004).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Piccart, M., Goldhirsch, A., Wood, W. et al. Keeping faith with trial volunteers. Nature 446, 137–138 (2007). https://doi.org/10.1038/446137a
Published:
Issue Date:
DOI: https://doi.org/10.1038/446137a
This article is cited by
-
Concordance as evidence in the Watson for Oncology decision-support system
AI & SOCIETY (2020)
-
Conflict of interest in academic oncology: moving beyond the blame game and forging a path forward
Blood Cancer Journal (2016)
-
Are we HER-ting for innovation in neoadjuvant breast cancer trial design?
Breast Cancer Research (2009)
-
Taking gene-expression profiling to the clinic: when will molecular signatures become relevant to patient care?
Nature Reviews Cancer (2007)